Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma : impact of alemtuzumab and donor lymphocyte infusions on long-term outcomesPEGGS, Karl S; SUREDA, Anna; MAHENDRA, Premini et al.British journal of haematology. 2007, Vol 139, Num 1, pp 70-80, issn 0007-1048, 11 p.Article

Effect of chemotherapy with alkylating agents on the yield of CD34⁺ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) StudyDE LA RUBIA, Javier; BLADE, Joan; CARRERA, Dolores et al.Haematologica (Roma). 2006, Vol 91, Num 5, pp 621-627, issn 0390-6078, 7 p.Article

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy : long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMABAUM, Linda G; MUNSHI, Nikhil C; PALOMERA, Luis et al.Blood. 2005, Vol 106, Num 12, pp 3677-3678, issn 0006-4971, 2 p.Article

High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphomaMONTOTO, Silvia; MORENO, Carol; ASENSIO, Antoni et al.Haematologica (Roma). 2008, Vol 93, Num 2, pp 207-214, issn 0390-6078, 8 p.Article

International and Italian prognostic indices in follicular lymphomaPEREA, Granada; ALTES, Albert; MARTINO, Rodrigo et al.Haematologica (Roma). 2003, Vol 88, Num 6, pp 700-704, issn 0390-6078, 5 p.Article

CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donorsPEREZ-GARCIA, Arianne; DE LA CAMARA, Rafael; GONZALEZ, Marcos et al.Blood. 2007, Vol 110, Num 1, pp 461-467, issn 0006-4971, 7 p.Article

Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx®), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II studyMARTINO, Rodrigo; PEREA, Granada; CABALLERO, Maria Dolores et al.Haematologica (Roma). 2002, Vol 87, Num 8, pp 822-827, issn 0390-6078Article

Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemiaBOSCH, Francesc; FERRER, Anna; ALTES, Albert et al.British journal of haematology. 2002, Vol 119, Num 4, pp 976-984, issn 0007-1048, 9 p.Article

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimensMONTESINOS, Pau; RAYON, Chelo; RIVAS, Concha et al.Blood. 2011, Vol 117, Num 6, pp 1799-1805, issn 0006-4971, 7 p.Article

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based ChemotherapyMONTESINOS, Pau; GONZALEZ, José D; DEBEN, Guillermo et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3872-3879, issn 0732-183X, 8 p.Article

Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control studyGALLARDO, David; DE LA CAMARA, Rafael; SERRANO, David et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1282-1288, issn 0390-6078, 7 p.Article

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemiaMONZO, Mariano; BRUNET, Salut; BUENO, Javier et al.Blood. 2006, Vol 107, Num 12, pp 4871-4879, issn 0006-4971, 9 p.Article

Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategyBRUNET, Salut; ESTEVE, Jordi; MONTSERRAT, Emili et al.Haematologica (Roma). 2004, Vol 89, Num 8, pp 940-949, issn 0390-6078, 10 p.Article